| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/15412555.2010.482115 |
| P698 | PubMed publication ID | 20486820 |
| P2093 | author name string | Annabelle Couillard | |
| Daniel Veale | |||
| Jean François Muir | |||
| P2860 | cites work | Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up | Q30806378 |
| Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data | Q31170687 | ||
| Psychological characteristics of patients with chronic obstructive pulmonary disease: a review | Q33227878 | ||
| Discriminative and predictive properties of disease-specific and generic health status indexes in elderly COPD patients | Q33359879 | ||
| Anxiety and depression in COPD: current understanding, unanswered questions, and research needs | Q33769925 | ||
| The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease | Q34546085 | ||
| Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease | Q47713684 | ||
| Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy | Q47728320 | ||
| Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries | Q47796539 | ||
| Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation | Q47798593 | ||
| Characteristics of physical activities in daily life in chronic obstructive pulmonary disease | Q47861320 | ||
| Relevance of assessing quadriceps endurance in patients with COPD. | Q47946769 | ||
| Physical activity and clinical and functional status in COPD. | Q50616985 | ||
| Depression and anxiety in elderly patients with chronic obstructive pulmonary disease. | Q50939779 | ||
| Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. | Q51054578 | ||
| Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. | Q51696699 | ||
| Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. | Q51705567 | ||
| Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation. | Q51707947 | ||
| Mortality after hospitalization for COPD. | Q51717351 | ||
| Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. | Q51717356 | ||
| Lung cancer death rates in lifelong nonsmokers. | Q51804779 | ||
| Relationship between functional loss before hospital admission and mortality in elderly persons with medical illness. | Q51925665 | ||
| Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. | Q52238999 | ||
| Anemia and inflammation in COPD. | Q52939727 | ||
| Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index. | Q53106078 | ||
| Physical activity in patients with COPD. | Q53124508 | ||
| Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. | Q54138868 | ||
| [Cardiovascular manifestations in patients with COPD]. | Q54374977 | ||
| Chronic Obstructive Pulmonary Disease Is Associated with Lung Cancer Mortality in a Prospective Study of Never Smokers | Q58260316 | ||
| Complex chronic comorbidities of COPD | Q58877111 | ||
| Epidemiology and costs of chronic obstructive pulmonary disease. | Q34563833 | ||
| Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. | Q35535679 | ||
| Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. | Q35536063 | ||
| Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD | Q35536881 | ||
| Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis | Q35537826 | ||
| Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease | Q36203206 | ||
| Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. | Q36225427 | ||
| From muscle disuse to myopathy in COPD: potential contribution of oxidative stress | Q36276581 | ||
| Heart failure and chronic obstructive pulmonary disease: An ignored combination? | Q36418960 | ||
| Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study | Q36600273 | ||
| Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis | Q36831910 | ||
| Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity | Q36919336 | ||
| Predictors of mortality in patients with stable COPD. | Q36979437 | ||
| BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD - a cross-sectional study | Q37061565 | ||
| Osteoporosis in chronic obstructive pulmonary disease patients | Q37095795 | ||
| Anxiety and depression in end-stage COPD. | Q37098365 | ||
| COPD as a systemic disease | Q37139528 | ||
| Predictors of Survival in COPD: more than just the FEV1. | Q37200986 | ||
| COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention | Q37231865 | ||
| Chronic obstructive pulmonary disease, anxiety, and depression: state of the science | Q37371209 | ||
| Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. | Q37375714 | ||
| Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators | Q37451068 | ||
| Systemic manifestations and comorbidities of COPD. | Q37465879 | ||
| Current status of research on osteoporosis in COPD: a systematic review | Q37536544 | ||
| Exertional desaturation in patients with chronic obstructive pulmonary disease | Q37638719 | ||
| The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. | Q40536343 | ||
| Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study | Q40603438 | ||
| Medical treatment of pulmonary hypertension in chronic lung disease | Q40733666 | ||
| Prediction of risk of COPD exacerbations by the BODE index. | Q41999462 | ||
| Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases | Q43770130 | ||
| Effects of severity of chronic obstructive pulmonary disease on thyroid function. | Q43816713 | ||
| Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease | Q44067405 | ||
| Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients. | Q44227365 | ||
| Catabolic/anabolic balance and muscle wasting in patients with COPD. | Q44508514 | ||
| Cardiovascular morbidity and mortality in COPD. | Q44933278 | ||
| Correlates of mortality in elderly COPD patients: focus on health-related quality of life | Q44979038 | ||
| Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. | Q46562371 | ||
| The metabolic syndrome in patients with chronic obstructive pulmonary disease | Q46628323 | ||
| Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass | Q47297954 | ||
| Predicting mortality in older patients. The VELCA Study | Q47335135 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 204-213 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | COPD: Journal of Chronic Obstructive Pulmonary Disease | Q5013430 |
| P1476 | title | COPD recent findings: impact on clinical practice | |
| P478 | volume | 7 |
| Q38036786 | COPD and associated comorbidities: a review of current diagnosis and treatment |
| Q85034339 | Chronic obstructive pulmonary disease and type 2 diabetes mellitus |
| Q55354282 | Chronic obstructive pulmonary disease: a complex comorbidity of lung cancer. |
| Q38085133 | Exercise and COPD: therapeutic responses, disease-related outcomes, and activity-promotion strategies |
| Q91923582 | Fibroblast Growth Factor 23 is Associated with a Frequent Exacerbator Phenotype in COPD: A Cross-Sectional Pilot Study |
| Q48855054 | Functional polymorphism of cyclooxygenase-2 gene (G-765C) in chronic obstructive pulmonary disease patients |
| Q51365018 | Relationship between body composition, peripheral muscle strength and functional exercise capacity in patients with severe chronic obstructive pulmonary disease. |
Search more.